Skip to content
Review

Bias from within: intracellular allosterism and the ICL2 hub.

Sep 2026 · TIPS - Trends in Pharmacological Sciences · Vol 47, pp. 1155-1170 · 0 citations · 115 references
Medicine

TL;DR

This work reviews emerging structure-activity relationships, mechanistic and evolutionary determinants of ICL2-targeted intracellular allostery, and key translational challenges including membrane accessibility, pharmacokinetics, and species divergence and highlights structure-guided and affinity-based discovery strategies for engineering pathway-selective intracellular AMs with greater transducer control than conventional orthosteric ligands.

Abstract

Targeting the orthosteric site of G protein-coupled receptors (GPCRs) has long dominated drug discovery, but intracellular allosteric modulators (AMs) provide new avenues to enhance selectivity and fine-tune signaling. Recent structural advances have illuminated intracellular allosteric pockets that act as conformational control hubs for transducer-selective engagement, biased signaling, and noncanonical receptor activation. Among these, the transmembrane helix 3 (TM3)-intracellular loop 2 (ICL2)-TM4 intracellular pocket (hereafter, the ICL2 site) has emerged as a key determinant of GPCR signaling bias and a strategic target for intracellular AM development. We review emerging structure-activity relationships, mechanistic and evolutionary determinants of ICL2-targeted intracellular allostery, and key translational challenges including membrane accessibility, pharmacokinetics, and species divergence. Finally, we highlight structure-guided and affinity-based discovery strategies for engineering pathway-selective intracellular AMs with greater transducer control than conventional orthosteric ligands.

View source

Similar papers

Open access Oct 2026

Fine-tuning an intracellular allosteric pocket programs GPCR signaling bias

Biased signaling of G protein-coupled receptors (GPCRs) offers a route for precise therapeutics with fewer adverse effects1. Intracellular allosteric ligands can impose such bias, yet how subtle chemical changes within these pockets reshape receptor-transducer coupling and downstream signaling remains unclear. Here, we...

Xin-Chao Shi, Rui-Di Zhu, Ke-Wei Chang et al. · 0 citations
Open access Oct 2026

Sparsely Phosphorylable Residues, Tuned by Agonist Chemotype, Shapes GPCR Signaling

It is shown that the melanocortin-4 receptor (MC4R), a central regulator of energy homeostasis, achieves remarkably diverse and pathway-selective signaling through a sparse set of strategically positioned regulatory phosphoresidues, arguing that GPCR signaling diversity does not necessarily require an extensive phospho...

M. Borah, Sarfraz Ahmed, Mahek Agrawal et al. · 0 citations
Nov 2026

Exploring Five-Membered S -Heterocyclic Scaffolds As Novel CaMKIIα Ligands Targeting the Hub Domain

The Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a brain-relevant kinase involved in long-term potentiation and synaptic plasticity. In continuation of our efforts exploiting the CaMKIIα hub domain representing the high-affinity target of γ-hydroxybutyrate (GHB), we herein report a study on five-mem...

L. Sirocchi, F. Bavo, S. J. Gauger et al. · 0 citations
Review Open access Nov 2026

DprE1 inhibitors in tuberculosis: integrating structural binding determinants, IC50-MIC translation, and physicochemical constraints for rational drug design.

Decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1) has emerged as one of the most validated and clinically relevant targets for antitubercular drug discovery. Although numerous DprE1 inhibitors have been reported across diverse chemical classes, the translation of enzymatic potency into consistent whole-cell and in v...

Fady H. Fayek, Mou-Sa H. A. Mai, Mona F. Said et al. · 0 citations
Open access Oct 2026

The Intersection of Allostery and Induced Proximity through the E3 Ligase Cereblon

Allostery modulates protein function through domains that are distinct from a protein’s orthosteric active site. In a therapeutic context, allosteric ligands provide mechanisms to overcome resistance, improve selectivity, and act cooperatively with orthosteric ligands. Separately, induced proximity modalities alter p...

Vanessa N. Dippon, Christina M. Woo · 0 citations
Open access Oct 2026

Molecular insights into GPR55 modulation reveal an atypical activation mechanism and glycosylation-dependent efficacy regulation

GPR55 is a lipid-activated G protein-coupled receptor (GPCR) implicated in metabolism, inflammation, and neurodegeneration. Lysophosphatidylinositol (LPI) species are proposed as endogenous agonists, but progress in understanding GPR55 function has still been limited by suboptimal chemical probes. Here, we present cryo...

T. Claff, Chamalee Demalgiriya-Gamage, A. B. Mahardhika et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.